Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-062112
Filing Date
2023-03-07
Accepted
2023-03-07 07:37:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d472271d424b5.htm 424B5 362893
2 GRAPHIC g472271g01k21.jpg GRAPHIC 35932
3 GRAPHIC g472271g03a03.jpg GRAPHIC 49251
  Complete submission text file 0001193125-23-062112.txt   481569
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255792 | Film No.: 23711048
SIC: 2836 Biological Products, (No Diagnostic Substances)